Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

153.80 +0.18 (+0.12%)
Streaming Delayed Price Updated: 3:54 PM EDT, Apr 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,534,760
Open 155.37
Bid (Size) 153.79 (2)
Ask (Size) 153.81 (1)
Prev. Close 153.62
Today's Range 152.24 - 155.63
52wk Range 140.68 - 169.99
Shares Outstanding 2,628,679,824
Dividend Yield 3.22%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
How Is The Market Feeling About Johnson & Johnson?
Via Benzinga
Johnson & Johnson's Q1 Results, FY Guidance Highlight The 'Power Of The Pharma Portfolio'
Johnson & Johnson (JNJ) reported upbeat Q1 results amid an exciting earnings season, with analysts noting impressive sales and guidance from the pharma giant. 
Via Benzinga

Performance

YTD
+6.8%
+6.8%
1 Month
-5.6%
-5.6%
3 Month
+6.3%
+6.3%
6 Month
-6.3%
-6.3%
1 Year
+4.2%
+4.2%

More News

Read More
Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Negative Currency Impact For 2025 Profit
Via Benzinga
2 Under-the-Radar Consumer Staples Stocks With Big Dividends
Via MarketBeat
Topics ETFs Intellectual Property World Trade
Exposures Intellectual Property Tariff
Johnson & Johnson Skids Despite First-Quarter Beat, Sales Guidance Hike
Via Investor's Business Daily
Topics Government Stocks
Exposures Political US Equities
Johnson & Johnson’s Q1 Earnings Beat Estimates, 2025 Guidance Revised To Account For Intra-Cellular Therapies Acquisition: Retail’s Positive
Via Stocktwits
Topics Earnings Government World Trade
Exposures Financial Political Tariff
Johnson & Johnson Reports Strong Q1 Performance
Via Talk Markets
Topics Stocks / Equities
Johnson & Johnson’s (NYSE:JNJ) Q1 Sales Top Estimates, Full-Year Sales Guidance is Optimistic
Via StockStory
Topics Intellectual Property
Exposures Intellectual Property
Johnson & Johnson Announces 63rd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.8%
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Reports Q1 2025 Results
From Johnson & Johnson
Via Business Wire
US Stock Futures Waver After Two-Day Rally: Trump's Tariff Moves Could End A 3-Year 'Rolling Recession,' Says Expert
Via Benzinga
Topics Government
Exposures Political
Citigroup, Bank Of America And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Earnings Scheduled For April 15, 2025
Via Benzinga
Johnson & Johnson Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Via Benzinga
US Stock Futures Slip As Investors Brace Themselves For Netflix, AmEx Earnings This Week — Nikkei Up On Strong Sentiment
Via Benzinga
34-Year-Old Making $3,400 a Month in Dividends Shares His Top 7 Stocks — 'Be Lucky and Save Relentlessly'
Via Benzinga
Johnson & Johnson (JNJ) Reports Earnings Tomorrow: What To Expect
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Examining the Future: Johnson & Johnson's Earnings Outlook
Via Benzinga
Are Tariff Worries Affecting The Earnings Outlook?
Via Talk Markets
Topics Stocks / Equities World Trade
Exposures Tariff
Novartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainties
Via Benzinga
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
2 Top Dividend Stocks to Buy Right Now
Via The Motley Fool
Topics Artificial Intelligence Government Lawsuit
Exposures Artificial Intelligence Financial Legal
S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash
Via Investor's Business Daily
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
Johnson & Johnson, Protagonist Tout Positive Results For Psoriasis Oral Pill Study
Via Benzinga
Alphabet To $185? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 153.80
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 04/16/25 03:54 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 404.29B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 404B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.